The collaboration leverages innovative stem cell science from the Cedars-Sinai Board of Governors ... Disclosure: Cedars-Sinai owns a minority stock interest in Emulate, Inc. An officer of Cedars-Sinai also serves on Emulate’s board of …
StemCells Inc ( STEM) stock plummeted on Tuesday following an announcement about one of its Phase II studies. StemCells said that it will no longer be pursuing its Phase II Pathway Study that was focused on spinal cord injuries. It …
The People’s Bank of China stood back after a global stock market rout last week, despite being widely expected to act. WSJ’s Gregor Stuart Hunter explains the bloodbath for Asian equities.
Europe enters a dangerous period after Greece’s Tsipras wins overwhelming victory China takes emergency measures to stem stock market panic China’s ‘Market Stabilization Fund’ mimics America’s ‘Organized Support’ in 1929 In lavish …
NeoStem, Inc. (Nasdaq: NBS) announced that it has entered into a definitive agreement to acquire California Stem Cell, Inc. ("CSC"), an Irvine, California based stem cell biotechnology company. As a result of this acquisition, NeoStem …
This marks the end of an era as a stem cell go-to stock. It has also been a public company since to the 1990s. It seems unlikely that there will be anything left for shareholders here. That being said, it is impossible to know how much, if …
WARF owns a small percentage of CDI stock and holds patents on some of ... president and chief executive of Stem Cell Theranostics, a California company that opened a Madison office in 2014. Al Rauch, a managing analyst with the State …
HONG KONG – Faced with a stomach-turning slide in share prices, many Chinese companies are taking matters into their own hands with a tactic that experts say is bound to backfire: they're pressing the pause button. About half of the 2,800 …